首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1935154

生物工程支架市場按應用、產品類型、給藥途徑、材質、最終用戶和地區分類

Bio-engineered Stent Market, By Application Type, By Product Type, By Mode of Delivery, By Material Type, By End User, By Geography

出版日期: 2026年01月27日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

生物工程支架市場預計在 2026 年達到 57.476 億美元，預計到 2033 年將達到 99.603 億美元，2026 年至 2033 年的複合年成長率為 8.7%。

報告覆蓋範圍		報告詳情
基準年：	2025	2026年市場規模：	57.476億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
預測期（2026-2033年）複合年成長率：	8.70%	2033 年的預測值：	99.603億美元

生物工程支架由短而細的金屬或塑膠管組成，用於治療阻塞的動脈。它們適用於患有各種心血管疾病的患者，包括心臟疾病和缺血性心臟疾病。市面上有多種生物工程支架可用於治療各種疾病，包括冠狀動脈疾病、周邊動脈疾病、頸動脈疾病、腎腹部主動脈血管瘤主動脈瘤和胸主動脈瘤。

市場動態

腎臟疾病盛行率的不斷上升是推動生物工程支架市場成長的主要因素。根據美國心臟協會理事會統計，2015年心血管疾病是全球首要死因，每年造成超過1,790萬人死亡，預計2030年將超過2,360萬人。根據同一資訊來源統計，2015年美國約有836,546人死於心血管疾病，約佔總死亡人數的三分之一。

此外，市場上的主要企業正致力於採取各種策略，例如推出新產品、獲得產品核准以及建立合作夥伴關係和開展合作，以鞏固其市場地位。例如，2017年5月，Medtronic獲得美國食品藥物管理局（FDA）的核准，推出了Resolute Onyx 4.5毫米和5毫米藥物釋放型支架。該產品已證實了Resolute Integrity支架的臨床性能和卓越的輸送性能。該產品旨在用於治療美國冠狀動脈疾病患者。

然而，心臟疾病治療領域替代品的出現、產品召回和故障，以及產品類型核准的嚴格監管，預計將阻礙市場成長。例如，2017年11月，雅培公司對其可吸收血管支架（BVS）系統（一種可吸收冠狀動脈藥物釋放型洗脫支架）發布了一級醫療器械召回令，原因是與使用Xience金屬藥物釋放型支架治療的患者相比，使用該系統的患者發生嚴重不利事件（如心肌梗塞和支架血栓症）的機率更高。

本次調查的主要特點

本報告以 2017 年為基準年，對生物工程支架市場進行了詳細分析，並提供了預測期（2018-2026 年）的市場規模和複合年成長率。
我們將重點介紹各個細分市場的潛在商機，並說明該市場具有吸引力的投資提案矩陣。
該研究還提供了有關市場促進因素、限制因素、機會、新產品發布或核准、市場趨勢、區域展望以及主要企業採取的競爭策略的重要見解。
本報告根據以下參數對全球生物工程支架市場的主要參與者進行了分析：公司概況、財務業績、產品類型組合、市場佔有率、分銷策略、主要發展、戰略和未來計劃。
本報告的研究結果將使負責人和企業經營團隊能夠就未來的產品發布、技術升級、市場擴張和行銷策略做出明智的決策。
這份全球生物工程支架市場報告針對該行業的各個相關人員，例如投資者、供應商、產品類型製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過各種用於分析生物工程支架市場的策略矩陣輕鬆做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 俄羅斯
- 其他歐洲
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 亞太地區的其他國家
中東
- GCC
- 以色列
- 其他中東地區
非洲
- 南非
- 中非
- 北非

第10章競爭格局

熱圖分析
市佔率分析
公司簡介
- Medtronic, plc.
- Boston Scientific Corporation
- Abbott Laboratories
- BIOTRONIK SE &Co. KG
- B. Braun Melsungen AG
- Terumo Corporation
- MicroPort Scientific Corporation
- STENTYS SA
- Meril Life Sciences Pvt. Ltd.
- Vascular Concepts
- WL Gore and Associates
- CR Bard
- Endologix, Inc.
- Lombard Medical Technologies
- Translumina GmbH
- JOTEC GmbH

第11章各節

參考
調查方法

簡介目錄

Product Code: CMI2484

Bio-engineered Stent Market is estimated to be valued at USD 5,747.60 Mn in 2026 and is expected to reach USD 9,960.3 Mn by 2033, growing at a compound annual growth rate (CAGR) of 8.7% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 5,747.60 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	8.70%	2033 Value Projection:	USD 9,960.3 Mn

Bio-engineered stents consist of short narrow metal or plastic tube, which is used to treat blocked arteries. It is used by patients who are suffering from different types of cardiovascular diseases such as coronary heart disease and ischemic heart disease. Different types of bio-engineered stent are available in market for various diseases such as coronary artery disease, peripheral arterial disease, carotid artery disease, renal artery stenosis, abdominal aortic aneurysm, thoracic aortic aneurysm among others.

Market Dynamics

Increasing prevalence of renal diseases is a major factor driving bio-engineered stents market growth. According to American Heart Association Council, in 2015, cardiovascular disease was the leading cause of death worldwide, accounting for over 17.9 million deaths annually and this number is expected to increase to over 23.6 million by 2030. According to the same source, cardiovascular diseases accounted for around 836,546 deaths in the U.S. in 2015, which accounted for around 1 in every 3 deaths.

Moreover, key players in the market are focused on adopting various strategies such as new Product Type launch and approvals and partnerships and collaborations to increase their foothold in the market. For instance, in May 2017, Medtronic plc., received the U.S. Food and Drug Administration (FDA) approval and Resolute Onyx, 4.5 MM and 5 mm sizes Drug-Eluting Stent. This device has proven clinical performance and superior deliverability of the Resolute Integrity. This device is intended to treat people with coronary artery disease in the U.S.

However, availability of alternatives for the treatment of cardiac diseases, Product Type recalls and failure, and stringent regulations for Product Type approvals are expected to hinder the market growth. For instance in November 2017, Abbott recall Class 1 Device Recall Absorb Bioresorbable Vascular Scaffold (BVS) System, an absorbable coronary drug-eluting stent due to elevated rates of major adverse events, specifically, myocardial infraction and scaffold thrombosis when compared to patients treated with the Xience metallic drug eluting stent.

Key features of the study

This report provides in-depth analysis of the bio-engineered stents market and provides market size (US$ million) and Compound Annual Growth Rate (CAGR %) for the forecast period (2018 - 2026), considering 2017 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the global bio-engineered stents market based on the following parameters - company overview, financial performance, Product Type portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Medtronic, plc., Boston Scientific Corporation, Abbott Laboratories, Biotronik SE & Co. KG, B. Braun Melsungen AG, Terumo Corporation, MicroPort Scientific Corporation, Stentys Sao, Meril Life Sciences Pvt. Ltd, Vascular Concepts, W. L. Gore and Associates, C. R. Bard, Endologix, Inc., Lombard Medical Technologies, Translumina GmbH, and Jotec GmbH
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global Bio-engineered stents market report caters to various stakeholders in this industry including investors, suppliers, Product Type manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the bio-engineered stents market

Market Segmentation

By Application Type
- Coronary artery disease
- Peripheral arterial disease
- Carotid Artery Disease
- Renal Artery Stenosis
- Abdominal Aortic Aneurysm
- Thoracic Aortic Aneurysm
- Others
By Product Type
- Drug-eluting Stents
- Bioabsorbable Stents
- Drug-eluting balloons
By Mode of Delivery
- Balloon-expandable Stents
- Self-expanding Stents
By Material Type
- Metal-based
- Polymer-based
By End User
- Hospitals & Cardiac Centers
- Ambulatory Surgical Centers
- Others
By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
Key Players
- Medtronic, plc.
- Boston Scientific Corporation
- Abbott Laboratories
- Biotronik SE & Co. KG
- Braun Melsungen AG
- Terumo Corporation
- MicroPort Scientific Corporation
- Stentys Sao
- Meril Life Sciences Pvt. Ltd
- Vascular Concepts
- L. Gore and Associates
- R. Bard
- Endologix, Inc.
- Lombard Medical Technologies
- Translumina GmbH
- JOTEC GmbH

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Application Type
- Market Snippet, By Product Type
- Market Snippet, By Material Type
- Market Snippet, By Mode of Delivery
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Market Trends
Impact Analysis
Key Highlights
PEST Analysis
PORTER's Analysis
Mergers and Acquisitions
Epidemiology

4. Global Bio-engineered Stent Market, By Application Type, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026- 2033
- Segment Trends
Coronary artery disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Peripheral arterial disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Carotid Artery Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Renal Artery Stenosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Abdominal Aortic Aneurysm
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Thoracic Aortic Aneurysm
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

5. Global Bio-engineered Stent Market, By Product Type, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026- 2033
- Segment Trends
Drug-eluting Stents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Bioabsorbable Stents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Drug-eluting balloons
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

6. Global Bio-engineered Stent Market, By Mode of Delivery, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026- 2033
- Segment Trends
Balloon-expandable Stents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Self-expanding Stents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

7. Global Bio-engineered Stent Market, By Material Type, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026- 2033
- Segment Trends
Metal-based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Polymer-based
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

8. Global Bio-engineered Stent Market, By End User, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026- 2033
- Segment Trends
Hospitals & Cardiac Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2026 - 2033, (USD Mn)

9. Global Bio-engineered Stent Market, By Region, 2026 - 2033, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2017-2033
North America
- Market Size and Forecast, By Application Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Mode of Delivery, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Material Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - U.S.
  - Canada
Latin America
- Market Size and Forecast, By Application Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Mode of Delivery, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Material Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Market Size and Forecast, By Application Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Mode of Delivery, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Material Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Size and Forecast, By Application Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Mode of Delivery, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Material Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of APAC
Middle East
- Market Size and Forecast, By Application Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Mode of Delivery, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Material Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Market Size and Forecast, By Application Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Product Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Mode of Delivery, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Material Type, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By End User, 2026 - 2033, (USD Mn)
- Market Size and Forecast, By Country, 2026 - 2033, (USD Mn)
  - South Africa
  - Central Africa
  - North Africa

10. Competitive Landscape

Heat Map Analysis
Market Share Analysis
Company Profiles
- Medtronic, plc.
  - Company Overview
  - Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Boston Scientific Corporation
  - Company Overview
  - Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Abbott Laboratories
  - Company Overview
  - Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- BIOTRONIK SE & Co. KG
  - Company Overview
  - Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- B. Braun Melsungen AG
  - Company Overview
  - Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Terumo Corporation
  - Company Overview
  - Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- MicroPort Scientific Corporation
  - Company Overview
  - Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- STENTYS SA
  - Company Overview
  - Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Meril Life Sciences Pvt. Ltd.
  - Company Overview
  - Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Vascular Concepts
  - Company Overview
  - Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- W. L. Gore and Associates
  - Company Overview
  - Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- C. R. Bard
  - Company Overview
  - Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Endologix, Inc.
  - Company Overview
  - Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Lombard Medical Technologies
  - Company Overview
  - Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- Translumina GmbH
  - Company Overview
  - Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
- JOTEC GmbH
  - Company Overview
  - Type Portfolio
  - Financial Overview
  - Key Highlights
  - Market Strategies
  - Analyst Views